Bill Text: CA AB24 | 2023-2024 | Regular Session | Amended
Bill Title: Emergency response: opioid antagonist kits.
Spectrum: Slight Partisan Bill (Democrat 4-2)
Status: (Failed) 2024-02-01 - From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. [AB24 Detail]
Download: California-2023-AB24-Amended.html
Amended
IN
Assembly
April 26, 2023 |
Amended
IN
Assembly
April 13, 2023 |
Amended
IN
Assembly
March 30, 2023 |
Amended
IN
Assembly
March 06, 2023 |
Introduced by Assembly Member Haney (Coauthors: Assembly Members Dixon, Ortega, Blanca Rubio, and Waldron) (Coauthor: Senator Cortese) |
December 05, 2022 |
LEGISLATIVE COUNSEL'S DIGEST
Digest Key
Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: YESBill Text
The people of the State of California do enact as follows:
SECTION 1.
Chapter 15 (commencing with Section 11860) is added to Part 2 of Division 10.5 of the Health and Safety Code, to read:CHAPTER 15. Opioid Antagonist Kit
CHAPTER 15.
11860.
For purposes of this chapter, the following definitions apply:(b)
(c)
(d)
(e)
11861.
(a) This chapter shall apply to designated facilities(1)Acquire an opioid antagonist kit for the designated facility.
(2)
(3)
(4)
(c)A designated facility or person that provides aid with an opioid antagonist kit stored at a designated facility is not liable for any civil damages resulting
from any acts or omissions in the rendering of emergency care by use of the opioid antagonist kit.
(d)
(e)
(1)(A)There is a shortage of opioid antagonists, as identified in subdivision (c) of Section 11862.
(B)In the event of a shortage, the department shall designate in which counties this chapter shall continue to apply.
11862.
The State Department of Public Health shall do each of the following:(c)
11863.
A person who violates any provision of this chapter may be subject to a civil penalty of not more than one hundred dollars ($100). This section shall not apply to a public entity or public employee.(a)A designated facility and its employees have no obligation to provide an opioid antagonist in the event of an opioid overdose or suspected opioid overdose and shall have no civil or criminal liability in the event that they fail to identify an opioid overdose or suspected opioid overdose or fail to provide or administer an opioid antagonist on their premises.(b)A designated facility shall not prohibit its employee from providing an opioid antagonist in the event of an apparent overdose.11864.
(a) This chapter does not affect the availability of any immunity otherwise applicable to a designated facility or its employees, including, but not limited to, Sections 2395 and 2727.5 of the Business and Professions Code, Sections 1714.2 and 1714.5 of the Civil Code, Sections 820.2 and 850.8 of the Government Code, and Section 1799.102 of the Health and Safety Code or create either of the following: